Startseite
Impressum
Datenschutz
 
Volume 36, 13 May 2005 5/2005
 
  SPOT ON

Antidepressants: life-threatening placebos?

 
  NEW ON THE MARKET
 

Duloxetine now as antidepressant: CYMBALTA

 
  THERAPIES FROM A CRITICAL VIEWPOINT
 

St John's wort (e.g. JARSIN): as good or bad as conventional antidepressants?
Primary prevention of atherosclerosis with aspirin
Do donepezil (ARIZEPT) and Vitamin E (e.g. EUSOVIT) help in "mild cognitive impairment" (MCI)?

 
  BEWARE MISINFORMATION
 

About the alleged bad bioavailability of lamotrigine-generics

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Advertisements in Turbomed-software

 
  IN BRIEF
 

Acupuncture for migraine: just a placebo-effect?
Does ciprofloxacin (e.g. CIPROBAY) inhibit the absorption of levothyroxine (e.g. EUTHYROX)?

 
  CURRENT ADR NETWORK REPORT
 

Suicidality with gabapentin (e.g. NEURONTIN)

 
  SIDE EFFECTS
 

Severe dermatitis and hypersensitivity with oxcarbazepine (TIMOX, TRILEPTAL)
"Atypical" neuroleptics increase mortality in dementia
Increased risk for endometrial cancer with tibolon (LIVIELLA)

 
© arznei-telegramm 5/2005